Skip to main content
Log in

Diuretics or β-Blockers First for Hypertension?

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Australian Therapeutic Trial in Mild Hypertension: Report by the Management Committee. Lancet 1: 1261–1267 (1980).

    Google Scholar 

  • Balin, L.J.; Bulpitt, C.J.; Coles, E.C.; Dollery, C.T.; Gear, J.S.W.; Harper, G.; Johnson, B.F.; Munro-Faure, A.D. and Turner, S.C.: Long-term anti-hypertensive drug treatment and blood pressure control in 3 hospital hypertension clinics. British Heart Journal 43: 74–79 (1980).

    Article  Google Scholar 

  • Bauer, J.H. and Brooks, C.S.: The long-term effect of propranolol on renal function. American Journal of Medicine 66: 405–410 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Brunner, H.R.; Laragh, J.H.; Baer, L; Newton, M.A.; Goodwin, F.T.; Krakoff, L.R.; Bard, R.H. and Buhler, F.R.: Essential hypertension: Renin and aldosterone, heart attack and stroke. New England Journal of Medicine 286: 441–449 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Buhler, F.R.; Laragh, J.G.; Baer, L.; Vaughan, E.D. and Brunner, H.R.: Propranolol inhibition of renin secretion. New England Journal of Medicine 287: 209–214 (1972).

    Article  Google Scholar 

  • Bullen, M.U.; Whitworth, J.A. and Kincaid-Smith, P.: Comparison of single dose and twice daily timolol therapy in mild hypertension. Medical Journal of Australia 2: 514–515 (1980).

    PubMed  CAS  Google Scholar 

  • Bulpitt, C.J.; Hoffbrand, B.I. and Dollery, C.T.: Contribution of drug treatment to symptoms of hypertension in patients; in Gross and Strasser (Eds) Mild hypertension: Natural History and Management, pp.291–302 (Pitman Medical, London 1979).

    Google Scholar 

  • Carney, S.; Gillies, A.I. and Morgan, T.: Optimal dose of a thiazide diuretic. Medical Journal of Australia 2: 692–693 (1976).

    PubMed  CAS  Google Scholar 

  • Curtis, J. and Horrigan, F.: Chlorthalidone induced hyperosmolar hyperglycaemic non ketotic coma. Journal of the American Medical Association 220: 1592–1593 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Doyle, A.E.: When to begin treatment in hypertension; in Kincaid-Smith and Whitworth (Eds) Hypertension: Mechanisms and Management (ADIS Press, Sydney, in press 1982).

    Google Scholar 

  • Doyle, A.E.; Jerums, G.; Johnston, C.I. and Louis, W.J.: Plasma renin levels in vascular complications in hypertension. British Medical Journal 2: 206–207 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Editorial: Hypertension in the over-sixties. Lancet 1: 1396 (1980).

  • Finnerty, F.A.; Maxwell, M.H.; Lunn, J. and Moser, M.: Long-term effects of furosemide and hydrochlorothiazide patients with essential hypertension. Angiology 28: 125–133 (1977).

    Article  PubMed  Google Scholar 

  • Goldman, A.; Stelle, B.; Schnaper, H.; Fitz, A.; Frohlich, E. and Perry, H.M.: Serum lipoprotein levels during chlorthalidone therapy. Journal of the American Medical Association 244: 1691–1695 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Grimm, R.H.; Leon, A.S.; Hunninghake, D.B.; Lenz, K.; Hannan, P. and Blackburn, H.: Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Annals of Internal Medicine 94: 7–11 (1981).

    PubMed  Google Scholar 

  • Harington, M.; Kincaid-Smith, P. and McMichael, J.: Results of treatment in malignant hypertension: A 7 year experience in 94 cases. British Medical Journal 2: 969–980 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Isles, C.; Brown, J.J.; Cuming, A.M.M.; Lever, A.F.; McAreavey, D.; Robertson, J.A.S.; Hawthorne, V.M.; Stewart, G.M.; Robertson, J.W.K. and Wapshaw, J.: Excess smoking in malignant phase hypertension. British Medical Journal 1: 579–581 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Jones, B. and Nanra, R.S.: Double blind trial of anti-hypertensive effect of chlorothiazide in severe renal failure. Lancet 2: 1258–1260 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Kincaid-Smith, P.; McMichael, J. and Murphy, E.A.: The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Quarterly Journal of Medicine, New Series XXVII: 117–153 (1958).

    Google Scholar 

  • Kohner, E.M.; Dollery, C.T.; Lowry, C. and Schumer, B.: Effect of diuretic therapy on glucose tolerance in hypertensive patients. Lancet 1: 986–990 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Laver, M.C.; Fang, P. and Kincaid-Smith, P.: Double-blind comparison of two beta-blocking drugs with previous therapy in the treatment of hypertension. Medical Journal of Australia 1: 174–176 (1974).

    PubMed  CAS  Google Scholar 

  • Leren, P.; Foss, P.O.; Helgeland, A.; Hjermann, I.; Holme, I. and Lund-Larsen, P.G.: Effect of propranolol and prazosin on blood lipids. Lancet 2: 4–6 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Medical Research Council Working Party Report on Mild to Moderate Hypertension: Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 2: 539–543 (1981).

    Google Scholar 

  • Metropolitan Life Insurance Company: Blood pressure: Insurance experience. Metropolitan Life Insurance Co.; New York (1961).

    Google Scholar 

  • Morgan, T.: Beta-adrenoreceptor blocking drugs in the treatment of hypertension. Australia and New Zealand Journal of Medicine 6: 612 (1976).

    Google Scholar 

  • Morgan, T.O.; Adam, W.R.; Hodgson, M. and Myers, J.: Duration of effect of different diuretics. Medical Journal of Australia 2: 315–316 (1979a).

    PubMed  CAS  Google Scholar 

  • Morgan, T.; Myers, J. and Carney, S.: The evidence that salt is an important aetiological agent, if not the cause of hypertension. Clinical Science 57: 457S–462S (1979b).

    Google Scholar 

  • Morgan, T.O.; Adam, W.R.; Hodgson, M. and Gibberd, R.S.: Failure of therapy to improve prognosis in elderly males with hypertension. Medical Journal of Australia 2: 27–31 (1980).

    PubMed  CAS  Google Scholar 

  • Mroczek, W.J.; Finnerty, F.A. and Catt, K.F.: Lack of association between plasma renin and history of heart attack or stroke in patients with essential hypertension. Lancet 2: 464–468 (1973).

    PubMed  CAS  Google Scholar 

  • Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New England Journal of Medicine 304: 801–807 (1981).

    Article  Google Scholar 

  • Parijs, J.; Joossens, J.V.; van der Linden, L.; Verstreken, G. and Amery, A.K.P.C: Moderate sodium restriction and diuretics in the treatment of hypertension. American Heart Journal 85: 22–34 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Reisen, E.; Abel, R.; Modan, M.; Silverberg, D.S.; Eliahou, H.E. and Modan, B.: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New England Journal of Medicine 198: 1–6 (1978).

    Article  Google Scholar 

  • Rudd, P.; Beilston, B.; Tul, V. et al.: Once daily regimen for propranolol antihypertensive therapy. Current Therapeutic Research 27: 29–39 (1980).

    Google Scholar 

  • Schnaper, H.; Fitz, A.; Frohlich, E.; Goldman, A.; Perry, H.M. and Steele, B.: Chlorthalidone and serum cholesterol. Lancet 2: 295 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Shaw, J.; England, J.D.F. and Hua, A.S.P.: Beta-blockers and plasma triglycerides. British Medical Journal 1: 986 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Tanaka, A.N.; Sagaguchi, K.; Oshige, K.; Niimura, T. and Kinehisa, T.: Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 25: 170–175 (1976).

    Article  Google Scholar 

  • Tarazi, R.C.; Dustan, H.P. and Frohlich, E.D.: Long-term thiazide therapy in essential hypertension. Circulation 41: 709–717 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Tweeddale, N.G. and Fodor, G.J.: Elevated serum uric acid: A cardiovascular risk factor? Nephron 23(Suppl. 1): 3–6 (1979).

    Article  PubMed  Google Scholar 

  • van den Brink, G.; Boer, P.; van ästen, P.; Dorhout Mees, E.J. and Geyskes, G.G.: One and three doses of propranolol a day in hypertension. Clinical Journal of Pharmacology and Therapeutics 27: 9–15 (1980).

    Article  Google Scholar 

  • Veterans’ Administration Co-operative Study Group on Anti-hypertensive Agents. Journal of American Medical Association 213: 1143–1152 (1970).

    Article  Google Scholar 

  • Waal-Manning, H.J.: Metabolic effects of β-adrenoreceptor blockers. Drugs 11(Suppl. 1): 121–126 (1976).

    Article  PubMed  Google Scholar 

  • Waal-Manning, H.J.: β-Blockers and labetalol. Current Therapeutics 22(6): 101–113 (1981).

    Google Scholar 

  • Walker, R.G.; Young, C.K.; Hua, A.S.P.; Thomas, G.W.; Whitworth, J.A. and Kincaid-Smith, P.S.: Tienilic acid in the treatment of mild to moderate hypertension. Clinical and Experimental Pharmacology and Physiology 7: 473–476 (1980).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whitworth, J.A., Kincaid-Smith, P. Diuretics or β-Blockers First for Hypertension?. Drugs 23, 394–402 (1982). https://doi.org/10.2165/00003495-198223050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198223050-00004

Keywords

Navigation